18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

18F-FDG PET/CT Plays a Limited Role in Replacing Bone Marrow Biopsy for Newly Diagnosed Advanced-Stage Patients With Extranodal Natural Killer/T-Cell Lymphoma

PurposeThe role of 18F-2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography (18F-FDG PET/CT) in evaluating bone marrow (BM) involvement (BMI) among patients with extranodal natural killer/T-cell lymphoma (ENKTL) is poorly understood. This study investigated whether PET/CT coul...

Full description

Bibliographic Details
Main Authors: Chunli Yang, Wanchun Wu, Huijie Zhou, Sha Zhao, Rong Tian, Maya Xiang, Liqun Zou
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
extranodal NK/T-cell lymphoma
18F-FDG PET/CT
bone marrow biopsy
bone marrow involvement
diagnosis
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.894804/full

Similar Items

Similar Items